Biomica Announces Participation at the 5th Microbiome Movement Drug Development Europe Conference on January 28-29, 2021 (Virtual Conference)
Share this article Share this article REHOVOT, Israel, Jan. 20, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), today announced it will be featured as a presenting company at the Microbiome Movement Drug Development Europe Conference. The conference is being held on January 28-29, 2021, virtually. Dr. Elran Haber, Biomica's Chief Executive Officer, is scheduled to speak on the European Microbiome Leaders Panel during the morning opening plenary sessi...
Source: prnewswire.com